Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

No association between deletion-type angiotensin-converting enzyme gene polymorphism and left-ventricular hypertrophy in hemodialysis patients.

Nephron - 1 Feb 2000

Yildiz A, Akkaya V, Hatemi A C, Cine N, Tükek T, Görçin B, Demirel S, Türk S, Sever M S

Abstract excerpt

Left-ventricular hypertrophy (LVH), a bad prognostic sign, is a common finding in hemodialysis patients. The aim of the study was to analyze factors, including angiotensin-converting enzyme (ACE) genotype that may have an effect on the development of LVH in hemodialysis patients. Seventy-nine hemodialysis patients (42 males, 37 females, mean age 37.7 +/- 13.1 years) and 82 age- and sex-matched normotensive...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Pressure
Share to DNA
Share to Echocardiography

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Gene Deletion

Share to Hypertrophy, Left Ventricular

Share to Kidney Failure, Chronic

Share to Peptidyl-Dipeptidase A

Share to Renal Dialysis

Source

Identifiers

PMID: 10657713
DOI: 10.1159/000045560

Genes

ACE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

No association between deletion-type angiotensin-converting enzyme gene polymorphism and left-ventricular hypertrophy in hemodialysis patients.PMID 10657713Read ↗

Angiotensin-converting enzyme gene insertion/deletion polymorphism and left ventricular hypertrophy in hemodialysis patients.Semantic proximity Read ↗

Insertion/deletion polymorphism in intron 16 of the ACE gene and left ventricular hypertrophy in patients with end-stage renal disease.Semantic proximity Read ↗

Angiotensin-converting enzyme polymorphism in patients with terminal renal failure.Semantic proximity Read ↗

The effect of angiotensin receptor blockade ARB on the regression of left ventricular hypertrophy in hemodialysis patients: comparison between patients with D allele and non-D allele ACE gene polymorphism.Semantic proximity Read ↗

Insertion/deletion polymorphism of the angiotensin-converting enzyme predicts left ventricular hypertrophy after renal transplantation.Semantic proximity Read ↗

ACE gene polymorphism, left ventricular geometry, and mortality in diabetic patients with end-stage renal disease.Semantic proximity Read ↗

Cardiac hypertrophy and remodeling in relation to ACE and angiotensinogen genes genotypes in Chinese dialysis patients.Semantic proximity Read ↗

Left ventricular myocardial mass index associated with cardiovascular and renal prognosis in IgA nephropathySemantic proximity Read ↗

Increased cardiovascular risk in long-term hemodialysis patients carrying deletion allele of ACE gene polymorphism.Semantic proximity Read ↗

Vitamin D receptor gene polymorphism predicts left ventricular hypertrophy in maintenance hemodialysis.Semantic proximity Read ↗

Deletion polymorphism of angiotensin-converting enzyme gene and left ventricular hypertrophy in southern Italian patients.Semantic proximity Read ↗

Association of interleukin-6 -174G/C promoter polymorphism with hypertension and left ventricular hypertrophy in dialysis patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.